BDRX
Biodexa·NASDAQ
--
--(--)
--
--(--)
BDRX Filings
Filing Date
Form Description
Form Type
2026-04-02
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-02 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-02
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-02 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-02
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-02 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-02
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-02 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-02
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-02 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-02
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-02 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-31
Form EFFECT - Notice of Effectiveness
2026-03-31 ·
Form EFFECT - Notice of Effectiveness
2026-03-31
Form EFFECT - Notice of Effectiveness
2026-03-31 ·
Form EFFECT - Notice of Effectiveness
2026-03-31
Form EFFECT - Notice of Effectiveness
2026-03-31 ·
Form EFFECT - Notice of Effectiveness
2026-03-31
Form EFFECT - Notice of Effectiveness
2026-03-31 ·
Form EFFECT - Notice of Effectiveness
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
